A citation-based method for searching scientific literature

Gillian S Dite, Robert J MacInnis, Adrian Bickerstaffe, James G Dowty, Richard Allman, Carmel Apicella, Roger L Milne, Helen Tsimiklis, Kelly-Anne Phillips, Graham G Giles, Mary Beth Terry, Melissa C Southey, John L Hopper. Cancer Epidemiol Biomarkers Prev 2016
Times Cited: 62



Yiwey Shieh, Donglei Hu, Lin Ma, Scott Huntsman, Charlotte C Gard, Jessica W T Leung, Jeffrey A Tice, Celine M Vachon, Steven R Cummings, Karla Kerlikowske, Elad Ziv. Breast Cancer Res Treat 2016
Times Cited: 64




List of shared articles



Times cited

Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.
Elke M van Veen, Adam R Brentnall, Helen Byers, Elaine F Harkness, Susan M Astley, Sarah Sampson, Anthony Howell, William G Newman, Jack Cuzick, D Gareth R Evans. JAMA Oncol 2018
56

The emerging field of polygenic risk scores and perspective for use in clinical care.
Tatiane Yanes, Aideen M McInerney-Leo, Matthew H Law, Shelly Cummings. Hum Mol Genet 2020
7

Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic Testing.
Elisha Hughes, Placede Tshiaba, Susanne Wagner, Thaddeus Judkins, Eric Rosenthal, Benjamin Roa, Shannon Gallagher, Stephanie Meek, Kathryn Dalton, Wade Hedegard,[...]. JCO Precis Oncol 2021
3

Towards a more precise and individualized assessment of breast cancer risk.
Marie E Wood, Nicholas H Farina, Thomas P Ahern, Melissa E Cuke, Janet L Stein, Gary S Stein, Jane B Lian. Aging (Albany NY) 2019
8

Validation of breast cancer risk assessment tools on a French-Canadian population-based cohort.
Rodolphe Jantzen, Yves Payette, Thibault de Malliard, Catherine Labbé, Nolwenn Noisel, Philippe Broët. BMJ Open 2021
1


Genetic Testing to Guide Risk-Stratified Screens for Breast Cancer.
Ava Willoughby, Paul R Andreassen, Amanda Ewart Toland. J Pers Med 2019
13


Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-BRCA1/2 breast cancer families.
Inge M M Lakeman, Florentine S Hilbers, Mar Rodríguez-Girondo, Andrew Lee, Maaike P G Vreeswijk, Antoinette Hollestelle, Caroline Seynaeve, Hanne Meijers-Heijboer, Jan C Oosterwijk, Nicoline Hoogerbrugge,[...]. J Med Genet 2019
14

Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field.
Tatiane Yanes, Mary-Anne Young, Bettina Meiser, Paul A James. Breast Cancer Res 2020
25

Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones.
Yiwey Shieh, Donglei Hu, Lin Ma, Scott Huntsman, Charlotte C Gard, Jessica W T Leung, Jeffrey A Tice, Elad Ziv, Karla Kerlikowske, Steven R Cummings. Breast Cancer Res Treat 2017
10

Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification.
Parichoy Pal Choudhury, Amber N Wilcox, Mark N Brook, Yan Zhang, Thomas Ahearn, Nick Orr, Penny Coulson, Minouk J Schoemaker, Michael E Jones, Mitchell H Gail,[...]. J Natl Cancer Inst 2020
34

Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.
Yiwey Shieh, Martin Eklund, Lisa Madlensky, Sarah D Sawyer, Carlie K Thompson, Allison Stover Fiscalini, Elad Ziv, Laura J Van't Veer, Laura J Esserman, Jeffrey A Tice. J Natl Cancer Inst 2017
80

Predicting Breast Cancer in Chinese Women Using Machine Learning Techniques: Algorithm Development.
Can Hou, Xiaorong Zhong, Ping He, Bin Xu, Sha Diao, Fang Yi, Hong Zheng, Jiayuan Li. JMIR Med Inform 2020
7

Breast cancer polygenic risk scores in the clinical cancer genetic counseling setting: Current practices and impact on patient management.
Molly McGuinness, Emily Fassi, Catharine Wang, Claire Hacking, Victoria Ellis. J Genet Couns 2021
3